Trials / Recruiting
RecruitingNCT06450444
The RECLAIM Study.
Randomized, Double-blind, Controlled Trial to Investigate Combined Occipital and Supra-orbital Neuromodulation in Resistant Migraine. The RECLAIM Study.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- Sponsor
- Salvia BioElectronics · Industry
- Sex
- All
- Age
- 18 Years – 84 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and performance, including clinical benefit, of the PRIMUS System for the treatment of Resistant Migraine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PRIMUS | The Salvia PRIMUS System is designed to provide subcutaneous neurostimulation to the branches of the trigeminal and occipital nerves. |
Timeline
- Start date
- 2024-06-24
- Primary completion
- 2027-04-01
- Completion
- 2029-01-31
- First posted
- 2024-06-10
- Last updated
- 2026-03-27
Locations
11 sites across 3 countries: Australia, Belgium, Netherlands
Source: ClinicalTrials.gov record NCT06450444. Inclusion in this directory is not an endorsement.